RxDataLab Platform

Every clinical trial change, automatically detected.

ClinicalTrials.gov doesn't notify you when a trial changes. We monitor every registered biotech trial daily and surface what changed: endpoint modifications, enrollment shifts, arm updates, and stopped trials. Organized by company.

$499/mo

Cancel anytime. Access continues through the end of the billing period.

450K+ trials monitored
500+ biotech companies tracked
Daily comparison against ClinicalTrials.gov
4 change categories detected

Detected this week

Recent trial changes caught automatically from ClinicalTrials.gov.

Updated Jul 6, 2026

Relay Therapeutics RLAY Mar 2
NCT04461496 Phase 2 Endpoint

Primary endpoint: Overall Response Rate → Progression-Free Survival

Beam Therapeutics BEAM Mar 1
NCT05144036 Phase 1 Status

Status: Recruiting → Active, not recruiting

Krystal Biotech KRYS Feb 28
NCT03356782 Phase 3 Enrollment

Enrollment: 45 → 120

Every item links to the original ClinicalTrials.gov record on the platform.

Change Detection

What gets caught.

ClinicalTrials.gov logs every update but doesn't surface them. We run a daily comparison and categorize every change.

Endpoint

Endpoint Modifications

Primary and secondary endpoint changes, new outcome measures added or removed, assessment timepoints shifted.

Enrollment

Enrollment Changes

Target enrollment updated, eligibility criteria modified, new sites added, age range or inclusion/exclusion criteria changed.

Status

Status Shifts

Recruiting, suspended, terminated, completed. Caught the day the registry updates. Stopped trials flagged immediately.

Study Arm

Study Arms

Arms added or dropped, dosing changes, new intervention branches, comparator updates across multi-arm studies.

Company Pipeline View

Trials organized by company.

Every company mapped to their complete pipeline. Trials with recent changes flagged automatically. Sample from Solid Biosciences Inc. (SLDB).

Solid Biosciences Inc. SLDB

4 recruiting
1 Phase 3
6 trials shown
Phase 3 ● Recruiting

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT...

NCT07160634 · 80 enrolled

Phase 1/2 ● Recruiting

A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

NCT06138639 · 60 enrolled

Phase 1 ● Recruiting

A Study of SGT-212 Gene Therapy in Friedreich's Ataxia

NCT07180355 · 10 enrolled

Phase 1 ● Recruiting

A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (...

NCT07148089 · 18 enrolled

Pipeline View

Every company's full trial pipeline in one view

500+ biotech companies mapped to their complete clinical trial pipelines. Every Phase 1 through Phase 3 trial, linked to the company, not buried under NCT IDs. See exactly where each program is, what changed recently, and what's running in parallel.

Change History

Changes buried in ClinicalTrials.gov sponsor updates, surfaced automatically

Catch every endpoint modifications, enrollment count changes, or new arm added or dropped. Status changes from recruiting to suspended. We run a daily comparison against the registry and log every update, categorized, timestamped, and linked to the original record. Complete change history per trial.

app.rxdatalab.com

What's included.

Clinical trial tracking is one part of a broader platform built for BD, investors, and strategy teams who work from primary sources.

Monitor trial changes automatically

Daily comparison against ClinicalTrials.gov catches endpoint modifications, enrollment changes, arm updates, and status shifts. Don't miss a thing.

Track a company's complete pipeline

500+ biotech companies mapped to their trials. Every Phase 1 through NDA, organized by company rather than NCT ID. Every item links to the original registry record.

Hedge fund positioning in biotech

13D/G ownership disclosures: who's building positions, reducing stakes, or going activist. Cross-referenced with trial events and 8-Ks.

See live data sample →

SEC filings classified by event type

8-K filings classified into financing events, FDA actions, clinical results, licensing deals, and strategic reviews. Search by company, date range, or type.

See live data sample →

Map competitive landscapes by indication

Search any indication. Every industry trial mapped using NLM's MeSH ontology. Overlay recent trial events across the competitive field.

Projects and notes that stay with the data

Company and trial watchlists. Timestamped notes on trial and company pages. Dashboard shows what changed across your coverage since your last session.

Pricing

Simple, transparent pricing.

Individual — Monthly

$499/mo

Billed monthly. Cancel anytime from your account page.

  • Full platform access
  • BioHedge (13D/G fund positioning)
  • Clinical trial change detection
  • 8-K signal detection
  • Competitive landscape mapping
  • Research workspace and notes
Subscribe Now →

Teams & Institutions

Custom pricing

For teams, firms, and institutional users who need multi-seat access, custom coverage, AI Access, API Access, or enterprise billing.

  • Multi-seat access
  • Custom data coverage and exports
  • Invoiced billing and enterprise contracts
  • API access and custom data feeds
  • Dedicated support

or email [email protected]

What happens after payment?

You'll receive a welcome email with a link to set your password. Access immediately once your password is set.

How do I cancel?

Go to your account page and click "Manage Billing." Access continues through the end of your billing period.

Do you offer trials or demos?

The public pages at app.rxdatalab.com/biohedge and app.rxdatalab.com/strategic-signals show live data and require no login.

Questions or enterprise pricing?

Email [email protected] for team access, institutional pricing, or anything else.

By subscribing you agree to our Terms of Service and Data License Agreement.